← Open Payments lookup

BITA JALILIZEINALI: Open Payments

NPI 1710006275 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,364 in 36 payments from 20 companies in 2025. Trend: 2023 $661 · 2024 $1,090 · 2025 $1,364

Food & beverage: $1,264Education: $100
CompanyPaymentsAmount
SANOFI-AVENTIS U.S. LLC4$178
Janssen Biotech, Inc.2$140
E.R. Squibb & Sons, L.L.C.1$122
Gamida Cell Inc.3$120
BeOne Medicines USA, Inc.1$112
Incyte Corporation3$84
SOBI, INC3$77
AstraZeneca Pharmaceuticals LP2$64
Syndax Pharmaceuticals, Inc.2$59
Gilead Sciences, Inc.1$56

Products named: REZUROCK, REBLOZYL, OMISIRGE, RYBREVANT, BRUKINSA, Vonjo, REVUFORJ, Yescarta.

Industry payments across NY — which companies pay providers there.